Constellation Pharmaceuticals (United States)
- Research works
- 114 ▼ 27% vs 2013–17
- Citations
- 7.1k 62.5 per fractional work
- Top-10% rate
- 29.0% record average 16.5%
- Open access
- 44% world 28%
Not ranked overall: Constellation Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.7×. Every wedge is a field page.
Who are the top researchers at Constellation Pharmaceuticals (United States)?
Ranked on the composite score, Richard Cummings, Patrick Trojer and Gozde Colak lead among researchers whose main affiliation is Constellation Pharmaceuticals (United States).
- 1 Richard Cummings United States · #217,473 worldwide 240 citations · 20 works
- 2 Patrick Trojer United States · #828,012 worldwide 51 citations · 19 works
- 3 Gozde Colak United States · #1,050,876 worldwide 11 citations · 17 works
Which keywords describe research at Constellation Pharmaceuticals (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Transcriptional Regulation, Epigenetic Regulation, BET Bromodomains, PROTACs, Cancer, DNA Methylation, Epigenetic Reprogramming and Histone Modification.
- Resistance
- Immunosuppression
- Mutational Signatures
- Myelofibrosis
- PET Imaging
- Targeted Therapy
- Transcription Factors
- m6A-seq
- Ubiquitin
- Gene Expression Regulation
- Epigenetics
- Histone Deacetylases
- International Myeloma Working Group
- Gene Expression
- Protein Arginine Methyltransferases
- Proteasome Inhibitors
- Histone Modification
- DNA Methylation
- Cancer
- Epigenetic Regulation
- Transcriptional Regulation
- BET Bromodomains
- PROTACs
- Epigenetic Reprogramming
- Cancer Therapy
- Arginine Methylation
- Staging System
- Diagnosis Criteria
- HDAC Inhibitors
- Tumor Microenvironment
- Cancer Progression
- Proteasome
- RNA methylation
- Gene Regulation
- Chromatin
- Transcription
- JAK2 Mutation
- Cancer Genomics
- Fibroblast Activation Protein
- N-terminal Acetylation
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Transcriptional Regulation24▲ 83×4 topics
- Epigenetic Regulation18▲ 71×4 topics
- BET Bromodomains13▲ 581×1 topic
- Cancer13▲ 8.4×14 topics
- PROTACs13▲ 581×1 topic
- DNA Methylation13▲ 100×2 topics
- Epigenetic Reprogramming13▲ 146×1 topic
- Histone Modification13▲ 176×1 topic
- Cancer Therapy13▲ 17×5 topics
- Proteasome Inhibitors11▲ 132×2 topics
- Arginine Methylation10▲ 256×1 topic
- Protein Arginine Methyltransferases10▲ 256×1 topic
- Staging System8▲ 113×2 topics
- Gene Expression8▲ 12×3 topics
- Diagnosis Criteria8▲ 226×1 topic
- International Myeloma Working Group8▲ 226×1 topic
- HDAC Inhibitors8▲ 340×1 topic
- Histone Deacetylases8▲ 340×1 topic
- Tumor Microenvironment4▲ 9.0×6 topics
- Epigenetics3▲ 48×2 topics
- Cancer Progression3▲ 11×2 topics
- Gene Expression Regulation3▲ 21×2 topics
- Proteasome3▲ 61×1 topic
- Ubiquitin3▲ 61×1 topic
- RNA methylation3▲ 29×1 topic
- m6A-seq3▲ 29×1 topic
- Gene Regulation3▲ 15×2 topics
- Transcription Factors3▲ 16×2 topics
- Chromatin2▲ 23×1 topic
- Targeted Therapy2▲ 9.7×4 topics
- Transcription2▲ 52×1 topic
- PET Imaging2▲ 9.4×3 topics
- JAK2 Mutation2▲ 94×1 topic
- Myelofibrosis2▲ 94×1 topic
- Cancer Genomics2▲ 34×1 topic
- Mutational Signatures2▲ 34×1 topic
- Fibroblast Activation Protein2▲ 30×1 topic
- Immunosuppression2▲ 14×2 topics
- N-terminal Acetylation2▲ 30×1 topic
- Resistance2▲ 14×2 topics
Which research topics does Constellation Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: Politics and Society in Latin America, Myeloproliferative Neoplasms: Diagnosis and Treatment, Multiple Myeloma Research and Treatments and Chronic Myeloid Leukemia Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Politics and Society in Latin America Political Science and International Relations 1 works
- 2 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 1 works
- 3 Multiple Myeloma Research and Treatments Hematology 1 works
- 4 Chronic Myeloid Leukemia Treatments Hematology 0 works
- 5 Cancer Genomics and Diagnostics Cancer Research 0 works
- 6 Cultural Insights and Digital Impacts Computer Networks and Communications 0 works
- 7 Protein Degradation and Inhibitors Molecular Biology 0 works
- 8 Genomics and Chromatin Dynamics Molecular Biology 0 works
- 9 Genomics and Phylogenetic Studies Molecular Biology 0 works
- 10 Geriatric Care and Nursing Homes General Health Professions 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Constellation Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 27% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Cambridge
- Harvard University
- Massachusetts Institute of Technology
- Center for Astrophysics Harvard & Smithsonian
- National Bureau of Economic Research
- IIT@MIT
- World Wide Web Consortium
- Broad Institute
- Smithsonian Astrophysical Observatory
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.